Macrogenics Inc

Macrogenics Inc

MGNX

Get informed when a big investor buys or sells

+ Follow
Market Cap$254.25M
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Macrogenics IncMacrogenics Inc-18.2--34%22.1
$-0.01

Current Fair Value

100.3% downside

Overvalued by 100.3% based on the discounted cash flow analysis.

Share Statistics

Market cap$254.25 Million
Enterprise Value$230.94 Million
Dividend Yield$- (-)
Earnings per Share$-1.18
Beta1.23
Outstanding Shares63,594,453

Return

Return on Equity-34.04%ROE
Return on Assets-4.22%
Return on Invested Capital-18.53%

Valuation & Multiples

P/E Ratio-18.18P/E Ratio
PEG11.82PEG
Price to Sales2.0Price to Sales
Price to Book Ratio-Price to Book Ratio
Enterprise Value to Revenue1.38
Enterprise Value to EBIT-5.27
Enterprise Value to Net Income-16
Total Debt to Enterprise0.39
Debt to Equity2.11Debt to Equity

Revenue Sources

No data

Insider Trades

Last Earnings Call

Report Date
August 13, 2026
EPS Estimate
$-0.08
Average shareholder expectation
Revenue Estimate
$59.14 M
Average shareholder expectation

Next Earnings Call

Expected Date
November 11, 2026
EPS Estimate
$-0.10
Average shareholder expectation
Revenue Estimate
$39.18 M
Average shareholder expectation

Institutional Put/Call Ratio

Market sentiment based on institutional option activity.

Put/Call Ratio0.5340 45.57%
Total Calls53,000 70.59%
Total Puts28,300 100.71%

Institutional Ownership

Holdings and activity of institutional investors.

Ownership %77.01% 8.97%
Total Invested$225.94M 81.11%
Investors Holding129 16.00%

ESG Score

No data

About Macrogenics Inc

CEO: Scott Koenig